Losk K, Freedman RA, Laws A, Kantor O, et al. Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center. Breast Cancer Res Treat 2020 Sep 16. pii: 10.1007/s10549-020-05931.
PMID: 32939592